Company Data

Voyager Therapeutics Inc.

Ticker
VYGR
Current Price
$5.51 -2.65%
Market Cap
$212.7M
Price Target
Refer to Report
Volume
49.2K
52wk Range
$2.54 - $10.6
Advanced Market Data

Overview

Voyager Therapeutics Inc is functional in the United States biotechnology industry. Its focus lies in the research and development of gene therapies for the cure of severe diseases of the central nervous system such as the Parkinson’s, Huntington’s and Alzheimer’s disease. The company has developed products such as VY-AADC01 for Advanced Parkinson’s Disease, VY-HTT01 for Huntington’s Disease. Voyager’s sole source of revenue is generated through its collaboration with a company called Genzyme. Genzyme funds the collaboration for the multiple gene therapy programs, including programs for Parkinson’s disease, Friedreich’s ataxia, and Huntington’s disease, as well as other CNS disorders.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
© 2018-2022 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.